400 related articles for article (PubMed ID: 12091599)
1. Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?
Eschbach JW; Varma A; Stivelman JC
Nephrol Dial Transplant; 2002; 17 Suppl 5():2-7. PubMed ID: 12091599
[TBL] [Abstract][Full Text] [Related]
2. Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients.
Movilli E; Cancarini GC; Zani R; Camerini C; Sandrini M; Maiorca R
Nephrol Dial Transplant; 2001 Jan; 16(1):111-4. PubMed ID: 11209002
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
Tarng DC; Huang TP; Chen TW; Yang WC
Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
[TBL] [Abstract][Full Text] [Related]
4. Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients.
DeVita MV; Frumkin D; Mittal S; Kamran A; Fishbane S; Michelis MF
Clin Nephrol; 2003 Nov; 60(5):335-40. PubMed ID: 14640239
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
[TBL] [Abstract][Full Text] [Related]
7. Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.
Ribeiro S; Garrido P; Fernandes J; Vala H; Rocha-Pereira P; Costa E; Belo L; Reis F; Santos-Silva A
Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):343-54. PubMed ID: 26889660
[TBL] [Abstract][Full Text] [Related]
8. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients.
Albitar S; Meulders Q; Hammoud H; Soutif C; Bouvier P; Pollini J
Nephrol Dial Transplant; 1995; 10 Suppl 6():40-3. PubMed ID: 8524493
[TBL] [Abstract][Full Text] [Related]
10. The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy.
Goodnough LT
Nephrol Dial Transplant; 2002; 17 Suppl 5():14-8. PubMed ID: 12091601
[TBL] [Abstract][Full Text] [Related]
11. The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).
De Schoenmakere G; Lameire N; Dhondt A; Van Loo A; Van der Goten J; Duym P; Vanholder R
Nephrol Dial Transplant; 1998 Jul; 13(7):1770-5. PubMed ID: 9681726
[TBL] [Abstract][Full Text] [Related]
12. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
[TBL] [Abstract][Full Text] [Related]
13. Effect of hyperparathyroidism on response to erythropoietin in children on dialysis.
Belsha CW; Berry PL
Pediatr Nephrol; 1998 May; 12(4):298-303. PubMed ID: 9655362
[TBL] [Abstract][Full Text] [Related]
14. Importance of iron supply for erythropoietin therapy.
Sunder-Plassmann G; Hörl WH
Nephrol Dial Transplant; 1995 Nov; 10(11):2070-6. PubMed ID: 8643170
[TBL] [Abstract][Full Text] [Related]
15. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
House AA; Pham B; Pagé DE
Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Br J Haematol; 1995 Jan; 89(1):17-23. PubMed ID: 7833259
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patients.
Kim DJ; Kim YM; Yun YS; Ahn CW; Cha BS; Song YD; Lim SK; Kim KR; Hahn JS; Huh KB; Lee HC
Diabet Med; 2003 Aug; 20(8):661-4. PubMed ID: 12873295
[TBL] [Abstract][Full Text] [Related]
18. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis.
Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P
Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554
[TBL] [Abstract][Full Text] [Related]
19. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
de Sousa FT; Prata MM; Barbas JV; dos Santos JP
Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
